Cannabis oil could be used to treat the rarest and most severe forms of epilepsy.
Known as CBD, the chemical has been incorporated within a new drug, called Epidiolex.
In early trials, the experimental drug was given to sufferers of Lennox-Gastaut syndrome, a form of epilepsy which triggers severe seizures.
Patients treated with the cannabis-derived compound experienced a 41.9 per cent reduction in 'drop seizures'—a type of fit that results in severe loss of muscle control and balance.Cannabis oil has previously been reported to help people with epilepsy, rheumatism, migraines, psoriasis, acne, multiple sclerosis and depression.
Crucially, cannabidiol oil does not contain any THC, the psychoactive component of cannabis. In other words, CBD does not get you high.
In the latest study researchers looked at patients who suffer from Lennox-Gastaut, a severe form of epilepsy which causes extreme seizures and significant mental disability.
There are currently six medications approved to treat this condition but patients are often still struck down with extreme bouts of fitting.
This study, led by Orrin Devinsky, professor of neurology, neurosurgery, and psychiatry at NYU School of Medicine, took 225 patients with the condition. These people ranged in age from two to 55 and were found around the world.
As part of the double-blind study, 76 patients received a large dose, 73 received a moderate dose and 76 were given a placebo.
Over a 14-week period of using cannabis oil, the drop in seizures was 41.9 per cent, 37.2 per cent and 17.2 per cent respectively. Study co-first author, Anup Patel, chief of Neurology at Nationwide Children's Hospital, added: 'This landmark study provides data and evidence that Epidiolex can be an effective and safe treatment for seizures seen in patients with Lennox Gastaut Syndrome, a very difficult to control epilepsy syndrome.'
'This new study adds rigorous evidence of cannabidiol's effectiveness in reducing seizure burden in a severe form of epilepsy and, importantly, is the first study of its kind to offer more information on proper dosing,' added Dr Devinsky.
Despite its success, the treatments often result in unwanted side-effects, which include: sleepiness, decreased appetite, diarrhoea, fever and vomiting.
The unwanted affects were described as mild to moderate.